Farms.com Home   News

CN Notes Prairie Grains Moving Smoothly to Port

Even with some of the challenges throughout the winter, one of Canada's national railways, CN, stated this week that grain is moving smoothly to the ports for export this spring.

The railway was affected by an 8 day strike in November and illegal blockades in February.  Executive Vice President of CN Rail, Shawn Finn notes that in the last two weeks CN has spotted very high number of cars.  In the winter, they target to spot 4,150 cars a week.  Last week they spotted 7,160 cars and this past week 6,900 cars.  Overall they are ahead of last years numbers in car spotting, metric tonnes moved in the past week, but are behind last years numbers in metric tonnes moved in the year, mainly due to the blockades in February.

The railway hit an all-time record in grain moved in March, which was 2.62 million tonnes, a 6.1 percent increase from 2017, the previous record for March.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.